Manchester Financial’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-326
Closed -$13K 157
2021
Q1
$13K Hold
326
0.01% 379
2020
Q4
$12K Sell
326
-55
-14% -$1.98K 0.01% 342
2020
Q3
$15K Hold
381
0.01% 268
2020
Q2
$13K Buy
381
+70
+23% +$2.52K 0.01% 280
2020
Q1
$10K Buy
311
+90
+41% +$3.52K 0.01% 286
2019
Q4
$10K Buy
+221
New +$9.25K ﹤0.01% 352
2019
Q3
Sell
-221
Closed -$9K 104
2019
Q2
$9K Buy
+221
New +$8.5K ﹤0.01% 322

Other funds holding BSX

Manchester Financial's BSX Position: Q2 2021 in Review

Manchester Financial sold out of Boston Scientific (BSX) in Q2 2021, closing a stake of 326 shares — an estimated $13K sold.

Manchester Financial first reported a position in BSX in Q2 2019 and held it in 7 quarters. The position peaked at $15K in Q3 2020. 867 funds tracked by Wall St. Rank hold BSX as of Q2 2021.

  • Manchester Financial reported no remaining Boston Scientific position as of Q2 2021 after selling out during the quarter.
  • Manchester Financial sold 326 Boston Scientific shares in Q2 2021, an estimated $13K.
  • Manchester Financial first reported a position in Boston Scientific in Q2 2019 and held it in 7 quarters.
  • Manchester Financial's Boston Scientific position peaked at $15K in Q3 2020.
  • 867 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2021.

Based on Manchester Financial's 13F filing for Q2 2021, filed 21 Jul 2021.